Considering the therapeutic effect of inhibiting KLF4 on the osteogenesis of Ano5−/− mCOBs, we speculated that the miR-34c-5p/KLF4 signaling pathway plays a vital role in the abnormal bone metabolism in GDD. This evidence concerns the gene ANO5 and gnathodiaphyseal dysplasia.